Gene promoter methylation is associated with increased mortality among women with breast cancer

Breast Cancer Research and Treatment

Volumn 121, Issue 3, 2010, Pages 685-692

  Xu, Xinran ^a   Gammon, Marilie D ^b   Zhang, Yujing ^c   Cho, Yoon Hee ^c   Wetmur, James G ^a   Bradshaw, Patrick T ^a   Garbowski, Gail ^c   Hibshoosh, Hanina ^c   Teitelbaum, Susan L ^a   Neugut, Alfred I ^c   Santella, Regina M ^c   Chen, Jia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Breast cancer; Epigenetics; Methylation; Mortality

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; PROTEIN P16;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; GENE SILENCING; GENES, APC; GENES, BRCA1; GENES, P16; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEW YORK; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS;

EID: 77953122596     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0628-2     Document Type: Article

References (39)

1. Landis SH, Murray T, Bolden S et al (1999) Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1
2. Gralow J, Ozols RF, Bajorin DF et al (2008) Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening a report from the American Society of Clinical Oncology. J Clin Oncol 26: 313-325
3. Richiardi L, Fiano V, Vizzini L et al (2009) Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 27: 3161-3168
4. Herman JG (1999) Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 9: 359-367 (Pubitemid 29532862)
5. Widschwendter M, Jones PA (2002) DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482
6. Ralhan R, Kaur J, Kreienberg R et al (2007) Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett 248: 1-17
7. Hopper JL (2001) Genetic epidemiology of female breast cancer. Semin Cancer Biol 11: 367-374 (Pubitemid 33016032)
8. Moller P, Evans DG, Reis MM et al (2007) Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status. Int J Cancer 121: 1017-1020 (Pubitemid 47101637)
9. Xu X, Gammon MD, Zhang Y et al (2009) BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 115: 397-404
10. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppresso-reviews on cancer. Biochim Biophys Acta 1332: F127-F147
11. Lin S, Xia W, Wang JC et al (2000) β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266 (Pubitemid 30226121)
12. Klarmann GJ, Decker A, Farrar WL (2008) Epigenetic gene silencing in the Wnt pathway in breast cancer, Epigenetics 3: 59-63
13. Muller HM, Widschwendter A, Fiegl H et al (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63: 7641-7645 (Pubitemid 37466689)
14. Rocco JW, Sidransky D (2001) p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264: 42-55
15. Yang X, Yan L, Davidson NE (2001) DNA methylation in breast cancer, Endocr Relat Cancer 8: 115-127
16. Birgisdottir V, Stefansson OA, Bodvarsdottir SK et al (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8: R38
17. Xu X, Gammon MD, Wetmur JG et al (2008) B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev 17: 2109-2116
18. Gammon MD, Neugut AI, Santella RM et al (2002) The Long Island Breast Cancer Study Project: description of a multiinstitutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74: 235-254
19. Gammon MD, Santella RM, Neugut AI et al (2002) Environmental toxins and breast cancer on Long Island I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 11: 677-685
20. Cleveland RJ, Eng SM, Abrahamson PE et al (2007) Weight gain prior to diagnosis and survival from breast cancer, Cancer Epidemiol Biomarkers Prev 16: 1803-1811 (Pubitemid 47450510)
21. McShane LM, Altman DG, Sauerbrei W et al (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK), Breast Cancer Res Treat 100: 229-235 (Pubitemid 44631925)
22. Eads CA, Danenberg KD, Kawakami K et al (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA Methyltransferase overexpression. Cancer Res 59: 2302-2306 (Pubitemid 29242272)
23. Eads CA, Lord RV, Kurumboor SK et al (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60: 5021-5026
24. Livak. KJ, Schmittgen TD (2001.) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408 (Pubitemid 34164012)
25. Rosner BA (2000) Fundamentals of biostatistics. Duxbury, Australia
26. Hosmer DW (1999) Applied survival analysis: regression modeling of time to event data. Wiley, New York
27. Rothman KJ, Greenland S (1998) Modern epidemiology. Lippincott-Raven Publishers, Philadelphia
28. Anonymous (2003) Cancer medicine. BC Decker Inc, Hamilton, London
29. Rosen EM, Fan S, Pestell RG et al (2003) BRCA1 gene in breast cancer, J Cell Physiol 196: 19-41
30. Liebens FP, Carly B, Pastijn A et al (2007) Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006. Eur J Cancer 43: 238-257 (Pubitemid 46123983)
31. Silvestrini R, Daidone MG, Luisi A et al (1995) Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol 13: 697-704
32. Osborne CK (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227-238 (Pubitemid 29054556)
33. Van der Auwera I, Van Laere SJ, Van den Bosch SM et al (2008) Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer 99: 1735-1742
34. Sunami E, Shinozaki M, Sim MS et al (2008) Estrogen receptor and HER2/neu status affect epigenetic differences of tumorrelated genes in primary breast tumors. Breast Cancer Res 10: R46
35. Tao MH, Shields PG, Nie J et al (2009) DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 114: 559-568
36. Wilson CA, Ramos L, Villasenor MR et al (1999) Localization of human BRCA1. and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21: 236-240 (Pubitemid 29070375)
37. Al-Mulla F, Abdulrahman M, Varadharaj G et al (2005) BRCA1 gene expression in breast cancer: a correlative study between real-time RT-PCR and immunohistochemistry. J Histochem Cytochem 53: 621-629 (Pubitemid 40593975)
38. Sington JD, Cottrell BJ (2002) Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings. J Clin Pathol 55: 499-502
39. Rich-Edwards JW, Coreano KA, Stampfer MJ (1994) Test of the national death index and equifax nationwide death search. Am. J Epidemiol 140: 1016-1019